0RP.SG - Tiziana Life Sciences Ltd

Stuttgart - Stuttgart Delayed price. Currency in EUR
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
Cost of revenue
0
-
0
0
0
Gross profit
0
-
0
0
0
Operating expenses
Research development
15,079
12,955
13,208
6,360
3,815
Selling general and administrative
855
0
855
14,023
-
Total operating expenses
14,896
14,586
27,374
32,273
10,193
Operating income or loss
-14,896
-14,586
-27,374
-32,273
-10,193
Interest expense
151
7
176
339.3434
94.4039
Total other income/expenses net
-804
-804
893
2,531
-
Income before tax
-14,154
-15,397
-26,657
-30,073
-10,287
Income tax expense
-3,240
0
-3,240
-2,343
-708.0296
Income from continuing operations
-10,914
-15,397
-23,417
-27,731
-9,579
Net income
-10,914
-15,397
-23,417
-27,731
-9,579
Net income available to common shareholders
-10,914
-15,397
-23,417
-27,731
-9,579
Basic EPS
-
-0.15
-0.24
-0.16
-0.03
Diluted EPS
-
-0.15
-0.24
-0.16
-0.03
Basic average shares
-
101,526
97,932
97,306
341,207
Diluted average shares
-
101,526
97,932
97,306
341,207
EBITDA
-
-15,339
-26,340
-29,637
-9,933